Brain Banking for Neurodegenerative Disease Studies

Brain banking has emerged as an indispensable pillar of research into Alzheimer’s disease, Parkinson’s disease, frontotemporal dementia and related disorders. By systematically collecting, processing and storing post-mortem brain tissue under stringent ethical and technical protocols, brain banks enable researchers to correlate clinical history with molecular and cellular pathology. Standardised approaches to consent, dissection, fixation, snap freezing and long-term storage help to minimise pre-analytical variability, thereby preserving protein, RNA and DNA integrity. High-quality brain specimens support a broad spectrum of studies, including immunohistochemistry, proteomics, transcriptomics and structural imaging, as well as the validation of fluid and imaging biomarkers. Collaborative networks and harmonised data-sharing platforms now link multiple centres across continents, enhancing statistical power and enabling comparative analyses of distinct patient populations. Together, these advances are charting new paths towards mechanistic insights, biomarker discovery and therapeutic target validation in neurodegenerative disease.

Research from Nature Portfolio

Recent studies have focused on the impact of pre-analytical factors on tissue quality. Investigations into cold ischaemia time have revealed that pH drift during the interval between organ removal and freezing can induce gene expression changes and compromise molecular assays. Detailed time-course analyses in model systems have established polynomial relationships between cold-ischaemia duration and tissue alkalosis, underscoring the need for rapid pH stabilisation protocols. This work has prompted refinement of standard operating procedures to include pH monitoring and buffering steps, with the aim of reducing stress-induced artefacts in human brain specimens. Emerging methods that integrate real-time pH measurement with automated sample handling are now being piloted to enhance reproducibility across brain banks.

Brain Banking for Neurodegenerative Disease Studies publication trend

The graph below shows the total number of articles in brain banking for neurodegenerative disease studies across all publications each year (not limited to Nature Index journals).

Technical terms

Postmortem interval (PMI): the elapsed time between death and commencement of tissue preservation, critical for maintaining molecular integrity.

Cold ischaemia time: the period between organ removal and freezing, during which biochemical changes such as pH drift may occur.

Snap freezing: rapid cooling of tissue, typically in liquid nitrogen, to arrest enzymatic activity and preserve molecular structures.

Neuropathological assessment: microscopic examination of brain specimens to identify hallmarks of neurodegenerative disease and to classify samples accurately.

Informed consent: the voluntary agreement by donors or next of kin for the collection, storage and research use of human tissue.

References

1. Individual Case Analysis of Postmortem Interval Time on Brain Tissue Preservation. PLOS ONE (2016).
2. BrainNet Europe’s Code of Conduct for brain banking. Journal of Neural Transmission (2015).
3. Control tissue in brain banking: the importance of thorough neuropathological assessment. Journal of Neural Transmission (2015).
4. Tissue alkalosis in cold-ischemia time. Scientific Reports (2017).